23 results match your criteria: "Vertebrobasilar Atherothrombotic Disease"

Cerebrovascular diseases (CVDs) are one of the leading causes of death and disability In Russia: they rank second in the structure of mortality from diseases of the circulatory system and in the overall mortality of the population. Successful treatment of CVD involves an integrated approach to the problem, taking into account the compensation of cardiovascular disorders, the elimination of neurological and psychopathological syndromes, the improvement of cerebral circulation and the use of neuroprotective agents that increase the resistance of brain tissue to hypoxia and ischemia. Insufficient clinical efficacy of neuroprotectors is due to a number of objective reasons, of which only two are universal.

View Article and Find Full Text PDF

Objective: The efficacy and safety of acute percutaneous transluminal angioplasty or stenting (PTA/PTAS) for vertebrobasilar artery occlusion with atherothrombotic brain infarction (ATBI) have not been confirmed despite the resistance to medical therapy alone. There are few reports about this disease and its treatment. Therefore, the treatment outcomes at our hospital were summarized to evaluate the efficacy and safety.

View Article and Find Full Text PDF

Background: Cranial artery dolichoectasia is characterized by dilated, elongated, and tortuous cranial arteries. Dolichoectasia and dolichoectatic aneurysm-particularly of the internal carotid arteries (ICAs)-are rare but can lead to stroke. We report a case of suspected recurrent acute cerebral infarction and dolichoectatic aneurysm of the left ICA combined with right dolichoectatic aneurysm, vertebrobasilar dolichoectasia, and atrial fibrillation.

View Article and Find Full Text PDF

[Clinical features of ischaemic stroke with cerebral venous insufficiency and its risk factors.].

Adv Gerontol

June 2019

Saint-Petersburg State University, 7-9, Universitetskaya emb., St. Petersburg, 199034, Russian Federation;

Current research aimed to reveal clinical and neurological features of ischaemic stroke (IS) in patients suffering from cerebral venous insufficiency (CVI) combined with arterial hypertension (AH) and to identify its risk factors. Examination data of 112 patients with IS (aged 60-93 years old; mean age 72,1±2,6 years old, males - 39 (34,8%), females - 73 (65,2%), admitted at regional vascular center of St. Elizabeth City Hospital in Saint Petersburg, highlighted that cephalgic syndrome and vestibulocerebellar dysfunction occurred more frequently in stroke patients with CVI.

View Article and Find Full Text PDF

Aim: to obtain more specific information on the morphology and pathogenesis of cerebral infarctions occurring in vertebrobasilar artery (VBA) atherosclerosis.

Material And Methods: Macro- and microscopic investigations of the brain, its arterial system, and heart were conducted in 69 autopsy cases with infarctions located in the vertebrobasilar system (VBS) in atherosclerosis.

Results: 69 cases were found to have 206 VBA infarctions of various extent and locations.

View Article and Find Full Text PDF

[Basilar artery occlusion--a diagnostic and therapeutic challenge].

Duodecim

July 2013

HYKS, neurologian klinikka, Meilahti ja Tutkimusohjelmayksikkö, molekyylineurologia ja neurotieteen osasto, kliininen laitos, Helsingin yliopisto.

Article Synopsis
  • - Acute basilar artery occlusion is a critical medical emergency that usually results in death or serious disability without prompt treatment through recanalization.
  • - Treatment options include intravenous thrombolytic therapy alone or in combination with endovascular procedures, but clear diagnosis via angiography is essential before proceeding.
  • - Causes of this condition often involve cardioembolism or thromboembolism from atherothrombotic disease, with systematic comparisons of treatment methods lacking, leading to reliance on local medical expertise for decision-making.
View Article and Find Full Text PDF

Background And Purpose: Acute vertebrobasilar occlusion is an ominous disease with few proved effective treatments. Experience with stent retrievers is scarce and limited to combined therapies (stent retrievers associated with previous intravenous fibrinolysis, intra-arterial thrombolysis, or other mechanical devices). We present our experience with 18 patients treated with direct thrombectomy by using stent retrievers.

View Article and Find Full Text PDF

Once atherosclerosis develops, stenosis (or occlusion) may occur in the lumen of various arteries of the living body. This can lead to a range of conditions, including myocardial infarction, cerebral infarction, aortic aneurysm and peripheral artery disease. The acronym 'ATIS' (AtheroThrombosIS) is a collective term for diseases characterized by a common course of development based on atherosclerosis.

View Article and Find Full Text PDF

Background: To determine the role of small vertebrobasilar artery (SVBA) in patients with posterior circulation stroke (PCS), we evaluated the ischemic patterns, collateral features, and stroke mechanisms in PCS patients with SVBA.

Methods: Ischemic findings on magnetic resonance (MR) imaging were correlated with 3D time-of-flight/contrast-enhanced MR angiography and/or catheter angiography in 18 patients (mean age, 68.0+/-11.

View Article and Find Full Text PDF

Objective: Temporal arteritis (TA) affects large arteries, including the vertebral arteries in up to 15% of cases. High resolution ultrasonography (US) is widely used for noninvasive imaging of the extracranial vertebral arteries. We assessed the prevalence of vertebrobasilar ischemia and structural abnormalities of the extracranial vertebral arteries by US in patients with TA and polymyalgia rheumatica (PMR) and in healthy controls.

View Article and Find Full Text PDF

Acute vertebrobasilar occlusion: current treatment strategies.

Neurol Res

November 2005

Allgemeines Krankenhaus Altona, Funktionsbereich Neuroradiologie, Hamburg, Germany.

Article Synopsis
  • Acute vertebrobasilar occlusion (VBO) is a serious condition with high mortality rates, which can potentially be lowered from 90% to 60% with local intraarterial fibrinolysis (LIF).
  • Combining intravenous Abciximab with intra-arterial rt-PA and using additional procedures like PTA/stenting may enhance brain function recovery and lower death rates, although it could lead to more bleeding issues overall.
  • The article discusses various treatment strategies for acute VBO, including different types of fibrinolysis, the use of GP IIb/IIIa inhibitors, and emerging mechanical devices for embolic occlusions.
View Article and Find Full Text PDF

In view of the poor prognosis for patients with acute intracranial vertebrobasilar occlusion (VBO), factors were sought that predict survival and good neurologic outcome after acute endovascular treatment by means of local intra-arterial fibrinolysis (LIF) and percutaneous transluminal angioplasty (PTA). LIF was performed in 83 patients with angiographically established acute VBO. A significant residual stenosis after LIF was treated by additional PTA in 8 patients.

View Article and Find Full Text PDF
Article Synopsis
  • Acute vertebrobasilar occlusion has high mortality rates even with treatment, and using platelet glycoprotein IIb/IIIa receptor inhibitors like abciximab may improve outcomes.
  • In a case study involving three patients treated within six hours of stroke onset, two received complete recanalization and improved to functional independence, while one patient showed partial improvement and later died.
  • The results suggest that combining abciximab with local tPA could be a promising treatment, but more research is needed to evaluate its effectiveness and bleeding risks.
View Article and Find Full Text PDF

Introduction: American trypanosomiasis, Chagas disease is caused by Trypanosoma cruzi. Between 10% and 30% of infected persons develop the chronic form, with predominance of the cardiac and gastrointestinal forms. Chagas myocardiopathy leads to congestive heart failure, dysrhythmias and thromboembolic phenomena, and may cause strokes.

View Article and Find Full Text PDF

[Analysis of ischemic stroke in patients aged up to 50 years].

Rinsho Shinkeigaku

September 2000

Cerebrovascular Division, Department of Medicine, National Cardiovascular Center, 5-7-1, Fujishirodai, Suita, Osaka 565-8565, Japan.

Background And Purpose: Ischemic stroke in young adults has not fully been studied in Japan. The purpose of this study is to clarify the clinical features and pathogenetic mechanisms of ischemic stroke in young adults.

Methods: From January 1990 to June 2000, 133 (7.

View Article and Find Full Text PDF

Only a few large series of posterior cerebral artery (PCA) stroke exist, and clinical features and causes have not been studied as extensively as in other vascular territories. The PCA syndrome includes more clinical signs than the well-known visual field deficits. Concomitant findings are frequently sensory, slight motor and neuropsychological deficits.

View Article and Find Full Text PDF

Recent studies suggest that high plasma levels of tissue-type plasminogen activator (tPA) and its inhibitor (plasminogen activator inhibitor-1, PAI-1) are markers of an increased risk of atherothrombotic ischemic events such as stroke and myocardial infarction. In this prospective study, we measured tPA antigen, PAI-1 antigen and activity, as well as tPA/PAI-1 complex in patients with acute stroke. Stroke subtypes were classified according to the TOAST criteria.

View Article and Find Full Text PDF
Article Synopsis
  • * An 83-year-old male patient experienced a locked-in syndrome due to a blockage caused by clotting and severe artery narrowing, prompting the intervention.
  • * While the procedure initially showed excellent results and the patient demonstrated good neurological recovery, he ultimately died from complications unrelated to the stent placement.
View Article and Find Full Text PDF

Antithrombotic therapy of acute stroke: thrombolytic agents.

Thromb Haemost

July 1997

Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.

Following the initial report of the clinical use of plasminogen activators (PAs) in cerebrovascular thrombosis in 1958, interest in the efficacy of this approach accelerated only when the need for acute intervention in stroke was recognized. The use of PAs in acute ischemic stroke is based on the observation that approximately 80-90% of focal cerebral ischemic events presenting as strokes within 8 hr of symptom onset are due to atherothrombotic and embolic occlusions.

View Article and Find Full Text PDF

Objective: the hospital referral of 200 patients with cerebrovascular disorders in order to evaluate the possibility of treating acute cerebral infarction.

Method: by means of a personalized interview an evaluation was made of the time that had passed between the start of the symptomatology and the time the patient went into hospital. The results were then grouped into intervals and compared to the different nosological entities of cerebral vascular pathology.

View Article and Find Full Text PDF

Prophylaxis and treatment of arterial embolism in high-risk patients includes therapy with antiplatelet drugs, anticoagulation, and vascular surgery. The prominent causes of cerebral ischemia are intraarterial emboli from atheromatous plaques and cardiac emboli. In patients with recent hemispheric transient ischemic attacks or minor stroke and ipsilateral high-grade internal carotid artery stenosis of 70 to 99% carotid endarterectomy has shown to be effective in prevention of major stroke or death.

View Article and Find Full Text PDF

A study was done of 31 episodes of transient loss of consciousness occurring at the onset of 557 cerebral ischaemic events selected on the basis of a well known mode of onset, excluding prolonged comas. The following conclusions can be drawn: Transient loss of consciousness is uncommon in ischaemic strokes (6.5 p.

View Article and Find Full Text PDF